1 Market Overview
1.1 Plasma Derived Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Plasma Derived Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Immunoglobulins
1.2.3 Albumins
1.2.4 Clotting Factors
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Plasma Derived Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Diagnostic Centers
1.3.6 Others
1.4 Global Plasma Derived Drugs Market Size & Forecast
1.4.1 Global Plasma Derived Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Plasma Derived Drugs Sales in Volume (2017-2028)
1.4.3 Global Plasma Derived Drugs Price (2017-2028)
1.5 Global Plasma Derived Drugs Production Capacity Analysis
1.5.1 Global Plasma Derived Drugs Total Production Capacity (2017-2028)
1.5.2 Global Plasma Derived Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Plasma Derived Drugs Market Drivers
1.6.2 Plasma Derived Drugs Market Restraints
1.6.3 Plasma Derived Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Grifols, S.A.
2.1.1 Grifols, S.A. Details
2.1.2 Grifols, S.A. Major Business
2.1.3 Grifols, S.A. Plasma Derived Drugs Product and Services
2.1.4 Grifols, S.A. Plasma Derived Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Octapharma
2.2.1 Octapharma Details
2.2.2 Octapharma Major Business
2.2.3 Octapharma Plasma Derived Drugs Product and Services
2.2.4 Octapharma Plasma Derived Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Antares Pharma
2.3.1 Antares Pharma Details
2.3.2 Antares Pharma Major Business
2.3.3 Antares Pharma Plasma Derived Drugs Product and Services
2.3.4 Antares Pharma Plasma Derived Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 CSL Limited
2.4.1 CSL Limited Details
2.4.2 CSL Limited Major Business
2.4.3 CSL Limited Plasma Derived Drugs Product and Services
2.4.4 CSL Limited Plasma Derived Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Plasma Derived Drugs Breakdown Data by Manufacturer
3.1 Global Plasma Derived Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Plasma Derived Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Plasma Derived Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Plasma Derived Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Plasma Derived Drugs Manufacturer Market Share in 2021
3.5 Global Plasma Derived Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Plasma Derived Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Plasma Derived Drugs Market Size by Region
4.1.1 Global Plasma Derived Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Plasma Derived Drugs Revenue by Region (2017-2028)
4.2 North America Plasma Derived Drugs Revenue (2017-2028)
4.3 Europe Plasma Derived Drugs Revenue (2017-2028)
4.4 Asia-Pacific Plasma Derived Drugs Revenue (2017-2028)
4.5 South America Plasma Derived Drugs Revenue (2017-2028)
4.6 Middle East and Africa Plasma Derived Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Plasma Derived Drugs Sales in Volume by Type (2017-2028)
5.2 Global Plasma Derived Drugs Revenue by Type (2017-2028)
5.3 Global Plasma Derived Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Plasma Derived Drugs Sales in Volume by Application (2017-2028)
6.2 Global Plasma Derived Drugs Revenue by Application (2017-2028)
6.3 Global Plasma Derived Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Plasma Derived Drugs Sales by Type (2017-2028)
7.2 North America Plasma Derived Drugs Sales by Application (2017-2028)
7.3 North America Plasma Derived Drugs Market Size by Country
7.3.1 North America Plasma Derived Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Plasma Derived Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Plasma Derived Drugs Sales by Type (2017-2028)
8.2 Europe Plasma Derived Drugs Sales by Application (2017-2028)
8.3 Europe Plasma Derived Drugs Market Size by Country
8.3.1 Europe Plasma Derived Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Plasma Derived Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Plasma Derived Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Plasma Derived Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Plasma Derived Drugs Market Size by Region
9.3.1 Asia-Pacific Plasma Derived Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Plasma Derived Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Plasma Derived Drugs Sales by Type (2017-2028)
10.2 South America Plasma Derived Drugs Sales by Application (2017-2028)
10.3 South America Plasma Derived Drugs Market Size by Country
10.3.1 South America Plasma Derived Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Plasma Derived Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Plasma Derived Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Plasma Derived Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Plasma Derived Drugs Market Size by Country
11.3.1 Middle East & Africa Plasma Derived Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Plasma Derived Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Plasma Derived Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Plasma Derived Drugs
12.3 Plasma Derived Drugs Production Process
12.4 Plasma Derived Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Plasma Derived Drugs Typical Distributors
13.3 Plasma Derived Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/